7411000087108: ZOSTAVAX 19400 plaque forming units per 0.65 milliliter powder and diluent for suspension for injection Merck Canada Inc. (real clinical drug)

SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...

\Vaccine product\Virus antigen-containing vaccine product\Vaccine product containing Human alphaherpesvirus 3 antigen (medicinal product)\Human alphaherpesvirus 3 antigen only vaccine product\...

\Vaccine product containing only Human alphaherpesvirus 3 antigen for herpes zoster prevention (medicinal product)\Zos ZOSTAVAX MC

\Varicella-zoster live attenuated vaccine\Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka strain antigen (medicinal product)\Live attenuated Human alphaherpesvirus 3 Oka-Merck strain only vaccine product\Zos ZOSTAVAX MC

\Product manufactured as parenteral dose form (product)\Zos ZOSTAVAX MC

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

104691000087115 Zos ZOSTAVAX MC en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

104711000087118 ZOSTAVAX 19400 plaque forming units per 0.65 milliliter powder and diluent for suspension for injection Merck Canada Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

104761000087116 Zona ZOSTAVAX MC fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)

138391000087112 ZOSTAVAX 19400 plaque forming units per 0.65 milliliter powder and diluent for suspension for injection Merck Canada Inc. (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Zos ZOSTAVAX MC	est un(e) (attribut)	Varicella-zoster vaccine (product)	false	Inferred relationship	Some
Zos ZOSTAVAX MC	Has supplier	Merck Canada Inc. (supplier)	true	Inferred relationship	Some
Zos ZOSTAVAX MC	a une forme pharmaceutique (attribut)	forme pharmaceutique pour usage parentéral (forme pharmaceutique)	true	Inferred relationship	Some
Zos ZOSTAVAX MC	Count of base of active ingredient	un	false	Inferred relationship	Some
Zos ZOSTAVAX MC	est un(e) (attribut)	Varicella-zoster live attenuated vaccine	false	Inferred relationship	Some
Zos ZOSTAVAX MC	Plays role	Active immunity stimulant role (role)	true	Inferred relationship	Some
Zos ZOSTAVAX MC	a pour principe actif (attribut)	Live attenuated Human alphaherpesvirus 3 Oka-Merck strain antigen	true	Inferred relationship	Some	1
Zos ZOSTAVAX MC	est un(e) (attribut)	Vaccine product containing only Human alphaherpesvirus 3 antigen for herpes zoster prevention (medicinal product)	true	Inferred relationship	Some
Zos ZOSTAVAX MC	est un(e) (attribut)	Product manufactured as parenteral dose form (product)	true	Inferred relationship	Some
Zos ZOSTAVAX MC	a pour principe actif (attribut)	Varicella virus vaccine (substance)	false	Inferred relationship	Some
Zos ZOSTAVAX MC	est un(e) (attribut)	Live attenuated Human alphaherpesvirus 3 Oka-Merck strain only vaccine product	true	Inferred relationship	Some
Zos ZOSTAVAX MC	est un(e) (attribut)	Varicella-zoster live attenuated vaccine (product)	false	Inferred relationship	Some
Zos ZOSTAVAX MC	a pour principe actif (attribut)	Varicella virus live vaccine (substance)	false	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Canada English language reference set (foundation metadata concept)

Administered tradename codes for vaccines reference set (foundation metadata concept)